Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Timmermans

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Diabetes Research (Edinburgh, Scotland)|July 1, 1989
Does non-enzymatic glycosylation affect complement function in diabetes?P W Peake, J A Charlesworth, V Timmermans, et al.
Australian and New Zealand Journal of Medicine|August 1, 1992
The value of complement measurements in the assessment of lupus activityL Milis, V Timmermans, C A Morris, et al.
International Journal of Immunopharmacology|January 1, 1991
The inhibitory effect of rosmarinic acid on complement involves the C5 convertaseP W Peake, B A Pussell, P Martyn, et al.
Clinical and Experimental Immunology|October 1, 1989
Differences in the metabolism of C4 isotypes in patients with complement activationP W Peake, B A Pussell, J A Charlesworth, et al.
Annals of the Rheumatic Diseases|September 1, 1988
Lymphocytotoxic antibodies in systemic lupus erythematosus: studies of their temperature dependence, binding characteristics, and specificity in vitroP W Peake, J D Greenstein, V Timmermans, et al.
Kidney International|September 1, 1990
Angiotensin II receptor regulation in anti-glomerular basement membrane nephritisV Timmermans, P W Peake, J A Charlesworth, et al.
Nature Biotechnology|August 14, 1998
Directed selection of MIP-1 alpha neutralizing CCR5 antibodies from a phage display human antibody libraryJ K Osbourn, J C Earnshaw, K S Johnson, et al.
Nucleic Acids Research|May 25, 1995
Regulation of the Saccharomyces cerevisiae DNA repair gene RAD16D D Bang, V Timmermans, R Verhage, et al.
Australian and New Zealand Journal of Medicine|April 1, 1989
The metabolism of C3 and C4 in patients with immune complexes and normal complement levelsJ A Charlesworth, P W Peake, J Golding, et al.
European Journal of Clinical Investigation|September 1, 1993
The platelet angiotensin II receptor in type I diabetes: studies in patients with and without nephropathyM Makarious, M Pawlak, L V Campbell, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Diabetes Research (Edinburgh, Scotland)|July 1, 1989
Does non-enzymatic glycosylation affect complement function in diabetes?P W Peake, J A Charlesworth, V Timmermans, et al.
Australian and New Zealand Journal of Medicine|August 1, 1992
The value of complement measurements in the assessment of lupus activityL Milis, V Timmermans, C A Morris, et al.
International Journal of Immunopharmacology|January 1, 1991
The inhibitory effect of rosmarinic acid on complement involves the C5 convertaseP W Peake, B A Pussell, P Martyn, et al.
Clinical and Experimental Immunology|October 1, 1989
Differences in the metabolism of C4 isotypes in patients with complement activationP W Peake, B A Pussell, J A Charlesworth, et al.
Annals of the Rheumatic Diseases|September 1, 1988
Lymphocytotoxic antibodies in systemic lupus erythematosus: studies of their temperature dependence, binding characteristics, and specificity in vitroP W Peake, J D Greenstein, V Timmermans, et al.
Kidney International|September 1, 1990
Angiotensin II receptor regulation in anti-glomerular basement membrane nephritisV Timmermans, P W Peake, J A Charlesworth, et al.
Nature Biotechnology|August 14, 1998
Directed selection of MIP-1 alpha neutralizing CCR5 antibodies from a phage display human antibody libraryJ K Osbourn, J C Earnshaw, K S Johnson, et al.
Nucleic Acids Research|May 25, 1995
Regulation of the Saccharomyces cerevisiae DNA repair gene RAD16D D Bang, V Timmermans, R Verhage, et al.
Australian and New Zealand Journal of Medicine|April 1, 1989
The metabolism of C3 and C4 in patients with immune complexes and normal complement levelsJ A Charlesworth, P W Peake, J Golding, et al.
European Journal of Clinical Investigation|September 1, 1993
The platelet angiotensin II receptor in type I diabetes: studies in patients with and without nephropathyM Makarious, M Pawlak, L V Campbell, et al.
Pageof 2